This NDC is on FDA's drug shortage list (posted Mar 10, 2023)
Product Information
CLONAZEPAM 2 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0398 per EA under NDC 16729013816. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on May 2, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729013816
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077147FDA Approved
5/2/2005
TE Code
AB
On Market Since
6/3/2011
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0398 per EA |
|---|---|
| All-time high | $0.0478 (Apr 15, 2020) |
| All-time low | $0.0316 (Nov 20, 2024) |
| 52-week high | $0.0436 |
| 52-week low | $0.0378 |
| Median price | $0.0380 |
| Average price | $0.0385 |
| Largest weekly change | -28.0% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0398 per EA (NDC 16729013816), effective Aug 19, 2026.
How has the price of CLONAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG TABLET?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 2 MG TABLET has ranged from a low of $0.0316 (Nov 20, 2024) to a high of $0.0478 (Apr 15, 2020), with a median of $0.0380 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONAZEPAM 2 MG TABLET?
CLONAZEPAM 2 MG TABLET (NDC 16729013816) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Is CLONAZEPAM 2 MG TABLET in shortage?
Yes — NDC 16729013816 is currently listed in FDA's drug shortage database (posted Mar 10, 2023).